The Effects of a Food Supplement, Based on Co-Micronized Palmitoylethanolamide (PEA)-Rutin and Hydroxytyrosol, in Metabolic Syndrome Patients: Preliminary Results.

Furthermore, although the difference between the groups did not reach statistical significance, the IL-6 plasma levels showed a trend reduction over time after the FS was administered (pre–post treatment 8.0 ± 1.73 pg/mL vs. 4.8 ± 1.20 pg/mL) but not after the placebo was administered (pre–post 5.6 ± 0.94 pg/mL vs. 5.01 ± 1.07 pg/mL).

also in 53,322 other papers